Isavuconazole Kinetic Exploration for Clinical Practice

BACKGROUND: Isavuconazole is a new antifungal prodrug for the treatment of invasive aspergillosis and mucormycosis. As no clear pharmacokinetic-pharmacodynamic relationship has been established for patients, therapeutic drug monitoring is not currently required. However, as isavuconazole is a new dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Darnaud, Léa, Lamoureux, Fabien, Godet, Cendrine, Pontier, Sandrine, Debard, Alexia, Venisse, Nicolas, Martins, Pauline, Concordet, Didier, Gandia, Peggy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277320/
https://www.ncbi.nlm.nih.gov/pubmed/30306415
http://dx.doi.org/10.1007/s40268-018-0251-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277320/
https://www.ncbi.nlm.nih.gov/pubmed/30306415
http://dx.doi.org/10.1007/s40268-018-0251-y

Ejemplares similares